Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Acrivon Therapeutics, Inc. shareholders
As of Sep 30, 2026, 45 institutions reported holding Acrivon Therapeutics, Inc., 49.4% of its shares. Largest: Ra Capital Management, L.P., Sands Capital Alternatives, LLC and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Acrivon Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 12.2M | 28.5% | no change | Nov 16, 2026 |
| Sands Capital Alternatives, LLC | 2.29M | 5.3% | no change | Nov 13, 2026 |
| Acadian Asset Management LLC | 1.32M | 3.1% | +153K | Nov 9, 2026 |
| Vanguard | 1.3M | 3.0% | +161K | Nov 13, 2026 |
| Wellington | 888K | 2.1% | no change | Nov 16, 2026 |
| Two Sigma | 565K | 1.3% | −76,542 | Nov 16, 2026 |
| Marshall Wace, LLP | 542K | 1.3% | +10,488 | Nov 13, 2026 |
| Bridgeway Capital Management, LLC | 378K | 0.88% | −964 | Nov 16, 2026 |
| Geode Capital | 297K | 0.69% | +31,520 | Nov 6, 2026 |
| BlackRock | 227K | 0.53% | −12,085 | Nov 13, 2026 |